Latest Industry Insights

By studying gene expression modifications induced by the immune response, Novigenix has developed a blood test for colorectal cancer. This Q&A with Jan Groen, CEO, provides insights on the test, and on the field of study that could revolutionize cancer diagnosis.

To ensure safety and consistency of products within the food industry, continual analysis through the production process is essential. We spoke to Ian Olmsted, from CEM Corporation, about ORACLE, an innovative solution that enables analysts to measure fat in food and much more without the fuss of traditional techniques.

The 67th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics is currently in full swing in Atlanta, Georgia. Bringing together over 6,500 scientists from across the globe, companies working in the mass spectrometry field also take this opportunity to share their latest developments and innovations. Here we will take a look at some of the release highlights for 2019.

We recently spoke to Richard Brand, CFO and Dhruvajyoti Roy, Director of Technology from the Laboratory for Advanced Medicine (LAM) to learn more about how LAM is developing methylation-based tests for the early detection and intervention of cancer.

Given that bad antibodies are likely to blame for a significant proportion of the reproducibility crisis in science, any efforts to reduce batch-to-batch variability are more than welcome. One company with a plan to help in this area is “Absolute Antibody”, who believe that recombinant antibodies are the way forward. To learn more about making antibodies with recombinant technology, we spoke to Ian Wilkinson, PhD, Chief Scientific Officer.

Having reliable antibodies can make or break your assay. However, sourcing the right antibody for the job can sometimes feel like you’re entering the lottery: there are so many on the market, and often they just don’t live up to what was promised. To learn more about antibody validation and its importance, we got in touch with Anthony Couvillon, PhD, Scientific Marketing Project Manager at Cell Signaling Technology.

Flow cytometry is a technique used to count and analyze the size, shape and properties of individual cells. Not just a valuable research tool, flow cytometry is also finding its stride in several clinical areas. Following BD Biosciences’ launch of a new sample preparation instrument, we spoke to Stephen Gunstream, VP and general manager, to get his insights on the role of flow cytometry in the clinic.

We recently spoke with Dr Lan Huang, CEO at BeyondSpring, a clinical-stage biopharmaceutical company to learn more about the company’s efforts to develop innovative immuno-oncology cancer therapies.

There are many reasons that one might want to detect microparticles in a sample, and equally many sources from which microparticles may be generated. Of growing interest recently is the identification of microplastics, not just in the environment but also in the food chain. We spoke to Harald Fischer, Marketing Director at WITec, about ParticleScout, their latest Raman-based solution for rapid identification of microparticles, and the role it can play in assisting microplastic studies.

Despite the great excitement about exosomes and their huge diagnostic and therapeutic potential, the technology needed to advance this work is lacking. We spoke to Jim West, CEO of Clara Biotech, who tells us how his team is working to fill that gap.